Sign In
Buy EMBC
$3.32
-0.170 (-4.87%)
At Close: Jun 03, 2026
Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results
06:30am, Thursday, 05'th Feb 2026
PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based med
embecta Announces Quarterly Cash Dividend
06:00am, Thursday, 05'th Feb 2026
PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstandi
Yacktman Fund's Strategic Moves: A Closer Look at Samsung Electronics Co Ltd
05:03pm, Monday, 02'nd Feb 2026
Insights from the Fourth Quarter of 2025 Yacktman Fund (Trades, Portfolio) recently submitted the N-PORT filing for the fourth quarter of 2025, providing insig
embecta to Report Fiscal First Quarter Financial Results
05:00pm, Thursday, 22'nd Jan 2026
PARSIPPANY, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based med
Embecta Corp. (EMBC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
06:45pm, Wednesday, 14'th Jan 2026
Embecta Corp. (EMBC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Comparing Embecta (NASDAQ:EMBC) & Organon & Co. (NYSE:OGN)
02:14am, Tuesday, 13'th Jan 2026
Organon and Co. (NYSE: OGN - Get Free Report) and Embecta (NASDAQ: EMBC - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the
Nutex Health (NASDAQ:NUTX) & Embecta (NASDAQ:EMBC) Head to Head Survey
02:48am, Monday, 05'th Jan 2026
Embecta (NASDAQ: EMBC - Get Free Report) and Nutex Health (NASDAQ: NUTX - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies b
embecta to Participate at the J.P. Morgan 2026 Healthcare Conference
05:00pm, Thursday, 18'th Dec 2025
PARSIPPANY, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P.
Head to Head Analysis: Embecta (NASDAQ:EMBC) vs. GoodRx (NASDAQ:GDRX)
03:42am, Thursday, 18'th Dec 2025
Embecta (NASDAQ: EMBC - Get Free Report) and GoodRx (NASDAQ: GDRX - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on th
Embecta Growth Stalls Despite Strong Fiscal 2025 Results (Rating Downgrade)
09:30am, Saturday, 29'th Nov 2025
Embecta Corp. (EMBC) faces a challenging fiscal 2026, with flat revenue and earnings growth expected - after a strong fiscal 2025. EMBC's weak outlook is driven by cannula costs, modest volume decline
Meet 33 Ideal "Safer" November Small/MidCap Value DiviBuys Of The S&P600
10:37am, Wednesday, 26'th Nov 2025
The S&P 600 Small/MidCap index offers high-yield dividend opportunities, with 33 out of 53 top-yielding stocks meeting both the 'safer' and IDEAL dividend Dogcatcher criteria. Top ten S&P600 dividend
Embecta Corp. (EMBC) Q4 2025 Earnings Call Transcript
11:23am, Tuesday, 25'th Nov 2025
Embecta Corp. ( EMBC ) Q4 2025 Earnings Call November 25, 2025 8:00 AM EST Company Participants Pravesh Khandelwal - VP & Head of Investor Relations Devdatt Kurdikar - President, CEO & Director Jake E
PARSIPPANY, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three- and t
embecta Announces Quarterly Cash Dividend
06:00am, Tuesday, 25'th Nov 2025
PARSIPPANY, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstandi
AXQ Capital LP Acquires Shares of 31,298 Embecta Corp. $EMBC
03:34am, Tuesday, 25'th Nov 2025
AXQ Capital LP acquired a new stake in Embecta Corp. (NASDAQ: EMBC) during the undefined quarter, according to its most recent filing with the SEC. The institutional investor acquired 31,298 shares of
